Actinomycosis: Follow-up

References

1. Schaal KP, Schofield GM. Classification and identification of clinically significant Actinomycetaceae. In: Ortiz-Ortiz L, Bojalil LF, Yakoleff V, eds. Biological, Biochemical, and Biomedical Aspects of Actinomycetes. Orlando, Fla: Academic Press; 1984:505-20.

2. Eastridge CE, Prather JR, Hughes FA Jr, Young JM, McCaughan JJ Jr. Actinomycosis: a 24 year experience. South Med J. Jul 1972;65(7):839-43. [Medline].

3. Richtsmeier WJ, Johns ME. Actinomycosis of the head and neck. CRC Crit Rev Clin Lab Sci. Nov 1979;11(2):175-202. [Medline].

4. Erikson D. Pathogenic anaerobic organisms of the Actinomyces group. Br Med Res Council Special Report Series. 1940;240:1.

5. Waksman SA, Henrici AT. The Nomenclature and Classification of the Actinomycetes. J Bacteriol. Oct 1943;46(4):337-41. [Medline].

6. Georg LK. The agents of human actinomycosis. In: Balows A, Dehau RM, Dowell VR, eds. Anaerobic Bacteria: Role in Disease. Springfield, Ill: Charles C Thomas; 1974:237-56.

7. Brock DW, Georg LK, Brown JM, Hicklin MD. Actinomycosis caused by Arachnia propionica: report of 11 cases. Am J Clin Pathol. Jan 1973;59(1):66-77. [Medline].

8. Behbehani MJ, Heeley JD, Jordan HV. Comparative histopathology of lesions produced by Actinomyces israelii, Actinomyces naeslundii, and Actinomyces viscosus in mice. Am J Pathol. Mar 1983;110(3):267-74. [Medline].

9. Najjar TA, McKeon J, Smith L, Parson R. Septic arthritis of TMJ secondary to experimental osteosynthesis. J Dent Res. 1980;59A:306.

10. Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36-year period. A diagnostic 'failure' with good prognosis after treatment. Arch Intern Med. Dec 1975;135(12):1562-8. [Medline].

11. Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. Sep 1984;94(9):1198-217. [Medline].

12. Coleman RM, Georg LK, Rozzell AR. Actinomyces naeslundii as an agent of human actinomycosis. Appl Microbiol. Sep 1969;18(3):420-6. [Medline].

13. Eng RH, Corrado ML, Cleri D, Cherubin C, Goldstein EJ. Infections caused by Actinomyces viscosus. Am J Clin Pathol. Jan 1981;75(1):113-6. [Medline].

14. Pine L, Overman JR. Determination of the structure and composition of the "sulphur granules" of Actinomyces bovis. J Gen Microbiol. Aug 1963;32:209-23. [Medline].

15. Brown JR. Human actinomycosis. A study of 181 subjects. Hum Pathol. Sep 1973;4(3):319-30. [Medline].

16. Lewis RP, Sutter VL, Finegold SM. Bone infections involving anaerobic bacteria. Medicine (Baltimore). Jul 1978;57(4):279-305. [Medline].

17. Peloux Y, Raoult D, Chardon H, Escarguel JP. Actinomyces odontolyticus infections: review of six patients. J Infect. Sep 1985;11(2):125-9. [Medline].

18. Metgud SC. Primary cutaneous actinomycosis: a rare soft tissue infection. Indian J Med Microbiol. Apr-Jun 2008;26(2):184-6. [Medline].

19. Schaal KP, Beaman BL. Clinical significance of actinomycetes. In: Goodfellow M, Mordarski M, Williams S, eds. The Biology of the Actinomycetes. New York: Academic Press; 1983:389-424.

20. Hennrikus EF, Pederson L. Disseminated actinomycosis. West J Med. Aug 1987;147(2):201-4. [Medline].

21. Lerner PI. Susceptibility of pathogenic actinomycetes to antimicrobial compounds. Antimicrob Agents Chemother. Mar 1974;5(3):302-9. [Medline].

22. Deshpande RB, Rao AA. Cervicofacial actinomycosis with upper cervical vertebral involvement and fatal meningitis (a case report). J Postgrad Med. Oct 1985;31(4):223-5. [Medline].

23. Holmberg K, Nord CE, Dornbusch K. Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica. Scand J Infect Dis. 1977;9(1):40-5. [Medline].

24. Boand A, Novak M. Sensitivity changes of Actinomyces bovis to penicillin and streptomycin. J Bacteriol. May 1949;57(5):501-8. [Medline].

25. Edelmann M, Cullmann W, Nowak KH, Kozuschek W. Treatment of abdominothoracic actinomycosis with imipenem. Eur J Clin Microbiol. Apr 1987;6(2):194-5. [Medline].

26. Abdalla J, Myers J, Moorman J. Actinomycotic infection of the oesophagus. J Infect. Aug 2005;51(2):E39-43. [Medline].

27. Aydin A, Erkiliç S, Bayazit YA, Koçer NE, Ozer E, Kanlikama M. Relation between actinomycosis and histopathological and clinical features of the palatine tonsils: a comparative study between adult and pediatric patients. Rev Laryngol Otol Rhinol (Bord). 2005;126(2):95-8. [Medline].

28. Kim TS, Han J, Koh WJ, Choi JC, Chung MJ, Lee JH, et al. Thoracic actinomycosis: CT features with histopathologic correlation. AJR Am J Roentgenol. Jan 2006;186(1):225-31. [Medline].

29. Lahoz Zamarro MT, Laguía Pérez M, Muniesa Soriano JA, Martínez Sanz G. [Base tongue actinomycosis]. Acta Otorrinolaringol Esp. May 2005;56(5):222-5. [Medline].

30. Ozcan C, Talas D, Görür K, Aydin O, Yildiz A. Actinomycosis of the middle turbinate: an unusual cause of nasal obstruction. Eur Arch Otorhinolaryngol. May 2005;262(5):412-5. [Medline].

31. Rothschild B, Naples V, Barbian L. Bone manifestations of actinomycosis. Ann Diagn Pathol. Feb 2006;10(1):24-7. [Medline].

32. Veselý J, Hýza P, Koncená J, Kuklínek I, Kozák J, Ranno R, et al. Unusual case of resistant actinomycosis following facial trauma. Acta Chir Plast. 2005;47(4):119-23. [Medline].

Further Reading

Keywords

actinomycosis, Actinomyces israelii, A israelii, inflammatory disease, bacterial infection, Actinomyces naeslundii, A naeslundii, Actinomyces viscosus, A viscosus, Actinomyces odontolyticus, A odontolyticus

Contributor Information and Disclosures

Author

Talib Najjar, DMD, MDS, PhD, Professor of Oral and Maxillofacial Surgery and Pathology, University of Medicine and Dentistry of New Jersey
Disclosure: Nothing to disclose.

Medical Editor

Janet Fairley, MD, Professor and Head, Department of Dermatology, University of Iowa
Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati
Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.